Grants for State governments - Health

The purpose of the Health Financing Activity (HFA) is to improve access to equitable and quality health services and prevent catastrophic health expenditure through increased resources for health, efficient allocation and utilization, and enhanced financial risk protection in alignment with Ethiopias overall aim of achieving Universal Health Coverage (UHC) through Primary Health Care (PHC) by 2035. Health care financing reform in Ethiopia, initiated in 1998, aimed to improve the quality and equity of health services. The strategy focused on increasing resources for health care, promoting efficiency, and ensuring long-term sustainability through multiple financing mechanisms. Key interventions included revenue retention at health facilities, a fee-waiver system, standardized exemption services, and the introduction of health insurance schemes. These reforms have significantly improved health service delivery and financial protection for citizens. USAIDs investments in healthcare financing reform are largely focused on strengthening and institutionalizing health care financing (HCF) functions and systems to support universal health coverage of quality primary health care (PHC) services for Ethiopian citizens with reduced financial barriers. The HFA will build upon the lessons derived from previous USAID Ethiopia Health Care financing reform initiatives, including the recent five-year Health Financing Improvement Program (HFIP). The expected outcomes will be evidence-based and objectively measured through the progress made in the country's capacity to achieve sufficient, equitable, sustainable, and efficient financing for universal healthcare coverage.

This grant provides researchers with access to advanced facilities and technical support for developing non-hormonal contraception and reproductive health products, without direct funding.

This grant provides funding for researchers to explore the interactions between the brain and immune system in the context of HIV and substance use disorders, aiming to identify new therapeutic targets and improve understanding of related neurological issues.

This funding opportunity provides financial support to state and territorial agencies to improve access to primary health care services for underserved populations by conducting needs assessments and enhancing workforce development.

The purpose of this program is to support states in developing and implementing certification systems for Certified Community Behavioral Health Clinics (CCBHCs), establish Prospective Payment Systems for Medicaid reimbursable behavioral health services, and prepare an application to participate in a four-year CCBHC Demonstration program.

This funding opportunity provides financial support to nonprofit organizations, government entities, and select for-profits for programs addressing substance use disorders in West Virginia, focusing on areas such as foster care, youth prevention, recovery housing, and workforce development.

This funding opportunity supports Ohio-based community organizations in developing innovative health programs that address and reduce health disparities among minority populations, focusing on prevention and lifestyle modifications.

This funding opportunity supports research projects that explore the basic mechanisms and effects of trained immunity in the innate immune system, targeting a wide range of institutions and researchers interested in immune responses and related diseases.

This funding opportunity provides state governments with financial assistance to enhance various public safety and criminal justice initiatives, including law enforcement, mental health programs, and technology improvements.

NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD aims to support postdoctoral scientists from diverse backgrounds in developing skills for translational research on Alzheimer's Disease and Related Dementias through mentorship and targeted research experiences.

This grant provides funding for research institutions and organizations to conduct early-stage clinical trials exploring the feasibility of music-based interventions for improving brain health in older adults with conditions like Alzheimer’s, Parkinson’s, and stroke.

This funding opportunity provides financial support to organizations that create and manage equine therapy programs aimed at improving the well-being and quality of life for disabled veterans and members of the Armed Forces.

This funding opportunity supports researchers in developing innovative animal models and biological resources to advance the understanding of Down syndrome and its related health conditions.

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the RNA Modifications Driving Oncogenesis (RNAMoDO) Initiative. It aims to promote mechanistic research in the emerging area of RNA modifications that drive oncogenesis, with a focus on the central role of RNA modifications in translational reprogramming of cancer cells. RNA modifications have been recognized to exert a substantial impact on gene expression and function and their de-regulation has been linked to the cancer phenotype. In particular, recent insights point to a crucial role for mRNA, tRNA, and rRNA modifications in translational reprogramming during tumor initiation, progression, and adaptation to therapy. However, the molecular mechanisms underlying this reshaping of the translatome caused by dynamic changes in RNA modifications, and especially the interplay between different RNA modifications within and across RNA molecules during translation, are not understood and represent the focus of this initiative. Historically, the research community has largely pursued investigations of RNA modifications by studying single RNA species and modification types. However, elucidating how dysregulation of mRNA, tRNA, and rRNA modifications reprograms translation to drive oncogenesis is not likely feasible for any single research laboratory, but will require the combination of expertise in mRNA, tRNA and rRNA biology, translational regulation, and cancer research. To stimulate progress in this emerging field, the RNAMoDO program will support collaborative research projects, preferably using an MPI structure, on how modifications in mRNA, tRNA, and rRNA molecules can drive the oncogenic process through translational reprogramming. To be responsive to the NOFO, each project will also explore the impact of interactions between modifications residing on the same or different RNA molecules during translation. This Notice of Intent to Publish (NOITP) is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in the early Fall of 2024, with an expected application due date in November 2024. The NOFO will utilize the U01 mechanism for Research Project Cooperative Agreement (Clinical Trial Not Allowed). Potential applicants are encouraged to view the presentation of this initiative to the NCI Board of Scientific Advisors (BSA), available at: (https://videocast.nih.gov/watch=54423) beginning at 1 hour, 32 minutes, 52 seconds. Presentation slides are downloadable at https://deainfo.nci.nih.gov/advisory/bsa/0324/Maas.pdf.

This funding opportunity supports researchers from various fields in developing innovative methods to study brain changes over time, focusing on both healthy individuals and those with specific cognitive or emotional challenges.

This funding opportunity supports researchers exploring heart, lung, and blood diseases and sleep disorders by providing access to valuable biospecimen collections for preliminary data generation.

This grant provides financial support for senior graduate students from diverse backgrounds to complete their dissertations in aging research, promoting a more inclusive scientific workforce.

This funding opportunity supports physician-scientists with clinical doctorate degrees who are transitioning to independent research careers in non-malignant hematology, enabling them to advance their research on blood disorders.

This funding opportunity supports research projects that develop and test strategies to overcome barriers to HIV prevention for individuals who use substances, particularly focusing on marginalized groups such as women, transgender individuals, and those involved in the criminal justice system.

This grant provides funding for innovative technology development projects that aim to create new tools and methods for advancing biomedical research, focusing on prototypes that address significant technical challenges.